Skip to main content
Top
Published in: Infection 6/2020

Open Access 01-12-2020 | COVID-19 | Brief Report

Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics

Authors: Thilo Westhofen, Giuseppe Magistro, Simon Lennartz, Jozefina Casuscelli, Christian Stief, Severin Rodler

Published in: Infection | Issue 6/2020

Login to get access

Abstract

Maintaining high-quality care for urological patients is a challenge during and after the Coronavirus disease 2019 (COVID-19) pandemic. We observe an increasing volume of postponed elective visits at our tertiary care hospital, holding the risk for deterioration of non-emergency disease conditions. As it is unclear for how long the pandemic will last, we propose to implement telehealth as a solution to provide regular symptom monitoring compatible with social distancing guidelines during the pandemic and beyond. Telemedical assessment and prioritizing of high-risk patients for individual consults at outpatient services will have to be aligned with available outpatient capacity and local outbreak severity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef
4.
go back to reference Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382:2327–36.CrossRef Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382:2327–36.CrossRef
5.
go back to reference Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382:1969–73.CrossRef Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382:1969–73.CrossRef
7.
go back to reference Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science (New York, NY). 2020;368:860–8.CrossRef Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science (New York, NY). 2020;368:860–8.CrossRef
9.
go back to reference Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197–8.CrossRef Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197–8.CrossRef
10.
go back to reference Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679–81.CrossRef Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679–81.CrossRef
Metadata
Title
Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics
Authors
Thilo Westhofen
Giuseppe Magistro
Simon Lennartz
Jozefina Casuscelli
Christian Stief
Severin Rodler
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01511-7

Other articles of this Issue 6/2020

Infection 6/2020 Go to the issue